Impact of immunotherapy as a monotherapy or in combination with conventional therapies on regulatory T-cell (Treg) modulation in prostate cancer: a systematic review

Olayemi Oluseun Akinnola, Ayomide Iyanuoluwa Olaniyan, Barnabas Adeoluwa Adeboye, Abimbola David Akinyosoye

Open source

DOI
10.1186/s12885-026-16550-w
Published
2026-07-17
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16550-w,
  title = {Impact of immunotherapy as a monotherapy or in combination with conventional therapies on regulatory T-cell (Treg) modulation in prostate cancer: a systematic review},
  author = {Olayemi Oluseun Akinnola and Ayomide Iyanuoluwa Olaniyan and Barnabas Adeoluwa Adeboye and Abimbola David Akinyosoye},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-16550-w},
  url = {https://doi.org/10.1186/s12885-026-16550-w}
}

RIS

TY  - JOUR
TI  - Impact of immunotherapy as a monotherapy or in combination with conventional therapies on regulatory T-cell (Treg) modulation in prostate cancer: a systematic review
AU  - Olayemi Oluseun Akinnola
AU  - Ayomide Iyanuoluwa Olaniyan
AU  - Barnabas Adeoluwa Adeboye
AU  - Abimbola David Akinyosoye
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-16550-w
UR  - https://doi.org/10.1186/s12885-026-16550-w
ER  - 

APA

Akinnola, O. O., Olaniyan, A. I., Adeboye, B. A., & Akinyosoye, A. D. (2026). Impact of immunotherapy as a monotherapy or in combination with conventional therapies on regulatory T-cell (Treg) modulation in prostate cancer: a systematic review. BMC Cancer. https://doi.org/10.1186/s12885-026-16550-w

Source records